Three pipettes with colored liquides, one is lifted up by a hand wearing blue gloves.

Up to two research calls per year

Research grants

Currently, the majority of our funding is awarded via research grants to academic institutions, although consortia including industry are welcome to apply.

Usually, two scheduled calls for research proposals are held each year. They can either be ‘All priorities’ calls which means that project topics should fit within one or more of EB-ResNet’s four strategic research priorities. Alternatively, a scheduled ‘Special’ call may be issued to invite proposals to address identified important unmet research questions, technology needs or clinical consequences arising from EB (e.g. chronic inflammation and fibrosis).

Project scope 'Research grants'

Fundamental to preclinical research, and clinical trials projects in EB
Research projects must fall into the scope of a current research call: either an 'All priorities' call or a 'Special call' i.e. chronic inflammation and fibrosis
Lead applicant: researchers and/or clinicians (cooperation with industry welcome and possible)
Project duration: 12 to 36 months
Funding: up to EUR 90,000.00 p.a.

Note that the project leader must have a contract of employment with the lead host institution/organisation at least for the time of the project period. Project lead salary and overheads/admin costs are not eligible. All research projects submitted have to be hypothesis driven and meet at least one of the EB-ResNet's research priorities. EB-ResNet does not fund any service provision (i.e. clinical testing) costs.

For applications from research consortia involving industry, but led by an academic partner, additional side-agreements may be required. Please also note our terms & conditions including revenue-sharing before submitting any application.

Upcoming calls

The next call for research proposals will open on 31 January 2020. Details on scope and submission deadlines are found under upcoming call.

Upcoming Call

All priorities call 2020

Last call

All priorities call 2019

Funded projects

Grant Round/ Call	Project lead	Organisation/ Institute	Duration	Research area	EB-type	Funder(s)
CIF Call 2018	Prof. Giovanna Zambruno	Bambino Gesu Ospedale, Italy	3 years	Clinical research RNA-therapy Fibrosis	Dystrophic	DEBRA Austria DEBRA UK DEBRA Spain
CIF Call 2018	Prof. Ulrich Rodeck	Thomas Jefferson University, USA	2 years	Clinical researh Small molecules Fibrosis	Dystrophic	DEBRA Austria DEBRA Ireland
CIF Call 2018	Dr. Yanling Liao	New York Medical College, USA	3 years	Clinical research Cancer	Dystrophic	DEBRA UK DEBRA Ireland
All Priorities 2019	Prof. Valerie Brunton	University of Edinburgh, UK	3 years	Fundamental research Cancer	Kindler	DEBRA Austria DEBRA UK
All Priorities 2019	Prof. Karine Raymond	Leiden University Medical Center, The Netherlands	3 years	Fundamental research Pluripotent stem cells	Simplex	DEBRA Austria
All Priorities 2019	Dr. Colin Butler	University College London, Great Ormond Street Institute of Child Health, UK	2 years	Fundamental research Cellular and molecular therapy	Junctional	DEBRA Austria DEBRA UK
All Priorities 2019	Prof. Liam Grover	University of Birmingham, UK	2 years	Preclinical research Small molecules	Dystrophic	DEBRA UK

Grant Round/Call	Project lead	Organisation/Institute	Duration	Research area	EB-type	Funder(s)
Innovative Research Grant Call 2017	Dr. Cédric Gaggioli Projectdetails	Association pour le Développement des Sciences Médicales, Faculté de Médicine, France	1 year	Fundamental research Small molecules	Dystrophic	DEBRA Austria
All Priorities Call 2018	Prof. Jouni Uitto Projectdetails	Thomas Jefferson University, USA	2 years	Fundamental research Molecular diagnostics	Dystrophic Junctional Simplex	DEBRA Austria
All Priorities Call 2018	Prof. Ganna Bilousova	University of Colorado, USA	3 years	Fundamental research Cellular and molecular therapy	Dystrophic	DEBRA Austria
All Priorities Call 2018	Dr. Su Lwin Projectdetails	Kings College London, UK	2 years	Gene therapy SSC	Dystrophic	DEBRA UK
All Priorities Call 2018	Prof. Gareth Inman	University of Glasgow	1 year	SSC	Dystrophic	DEBRA UK

Grant Round/Call	Project lead	Organisation/Institute	Duration	Research area	EB-type	Funder(s)
All Priorities Call 2017	Prof. Cristina Has Projectdetails	University of Freiburg, Germany	1 year	Fundamental research Genetics	Simplex	DEBRA Austria
All Priorities Call 2017	Dr. Antonia Reimer Projectdetails	University of Freiburg, Germany	3 years	Fundamental research Clinical characterization	Dystrophic Junctional	DEBRA Austria
Innovative Research Grant Call 2017	Prof. Margarita Calvo Projectdetails	Pontificia Universidad Católica de Chile, Chile	1,5 years	Fundamental research Small molecules Symptom relief	Dystrophic	DEBRA Austria
All Priorities Call 2017	Prof. Daniele Castiglia Projectdetails	IRCCS, Rome, Italy	3 years	Fundamental research Small molecules Woundhealing	Dystrophic	DEBRA Austria
All Priorities Call 2017	Prof. Thomas Magin Projectdetails	University of Leipzig, Germany	3 years	Fundamental research Small molecules	Simplex	DEBRA Austria
All Priorities Call 2017	Prof. Alain Hovnanian Projectdetails	INSERM, Departement of Genetics, France	2 years	Fundamental research Cellular and molecular therapy	Dystrophic	DEBRA Austria
CliniCall 2015	Prof. Peter Marinkovich	Stanford University, USA	3 years	Clinical trial Phase II Cellular and molecular therapy	Dystrophic	DEBRA Austria